Table 1.
Variables included in the CDMa conceptual mapping exercise, with counts subsequently reported monthly.
Data item | OMOPb (Y=yes, N=no) | Data source | |||
Demographics | |||||
|
Gender | Y | Standardized sex (gender) codes are used in OMOP CDM mapping. Date of birth and age concepts also exist. | ||
|
Age band | Y | Date of birth and age concepts exist in OMOP. | ||
SESc quintile | |||||
|
The Index of Multiple Deprivation (IMD, a set of relative measures of deprivation for small areas [lower-layer super-output areas) across England, based on 7 domains of deprivation), in England, the Scottish Index of Multiple Deprivation (SIMD), the Welsh Index of Multiple Deprivation (WIMD), and the Northern Ireland Multiple Deprivation Measure (NIMDM) | N | Does not exist in the OMOP CDM. It can be introduced as a custom mapping in all UK databases within OMOP. It is to be harmonized across the DaC-VaPd data partners (quintile 5 most deprived, quintile 1 least deprived). | ||
Other characteristics | |||||
|
BMI>30/obesity | Y | Will be found in the measurement table or from a diagnosis of obesity. | ||
|
Smoking status | Y | Will be found in the observation table. | ||
Vaccination | |||||
|
Vaccine type | Y | Will be found in the drug, procedure, and event tables. For England, the source codes are dm+de or SNOMED CTf. | ||
|
Vaccine dose | Y | In vaccine administration. | ||
|
Vaccination date | Y | Date of event when the event is COVID-19 vaccination. | ||
Exemplar AEIsg | |||||
|
CVSTh | Y | Will be found in the condition table. It is mapped to SNOMED CT or Read v2. We did not include medications in this feasibility study. | ||
|
Anaphylaxis | Y | Will be found in the condition table. It is mapped to SNOMED CT or Read v2. We did not include medications in this feasibility study. |
aCDM: common data model.
bOMOP: Observational Medical Outcomes Partnership.
cSES: socioeconomic status.
dDaC-VaP: Data and Connectivity COVID-19 Vaccines Pharmacovigila.
edm+d: Dictionary of Medicines and Devices.
fSNOMED CT: Systematized Nomenclature of Medicine Clinical Trials.
gAEI: adverse event of interest.
hCVST: cerebral venous sinus thrombosis.